Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Talbot

Showing results (101-110 of 255) with videos related to

Pageof 26
Sort By:
Cell Death & Disease|January 31, 2026
Mutant TDP-43 drives impairments in axonal transport and glycolysis in a mouse stem-cell-derived motor neuron model of amyotrophic lateral sclerosis (ALS)Emily Carroll, Jakub Scaber, Iris-Stefania Pasniceanu, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 17, 2020
Motor Neuron Disease Register for England, Wales and Northern Ireland-an analysis of incidence in EnglandSarah Opie-Martin, Lynn Ossher, Andrea Bredin, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|December 17, 2009
Pattern of spread and prognosis in lower limb-onset ALSMartin R Turner, Alice Brockington, Jakub Scaber, et al.
FEBS Letters|June 5, 2007
Crystal structure of human wildtype and S581L-mutant glycyl-tRNA synthetase, an enzyme underlying distal spinal muscular atrophyMuhammed Z Cader, Jingshan Ren, Paul A James, et al.
Annals of Clinical and Translational Neurology|July 16, 2020
CSF chitinases before and after symptom onset in amyotrophic lateral sclerosisElizabeth Gray, Alexander G Thompson, Joanne Wuu, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 30, 2015
The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosisElizabeth Gray, James R Larkin, Tim D W Claridge, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 2, 2022
A survey of current practice in genetic testing in amyotrophic lateral sclerosis in the UK and Republic of Ireland: implications for future planningHugo M De Oliveira, Arunachalam Soma, Mark R Baker, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 1, 2020
Development of LNA Gapmer Oligonucleotide-Based Therapy for ALS/FTD Caused by the C9orf72 Repeat ExpansionChaitra Sathyaprakash, Raquel Manzano, Miguel A Varela, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 17, 2021
Isolated homozygous R217X <i>OPTN</i> mutation causes knock-out of functional C-terminal optineurin domains and associated oligodendrogliopathy-dominant ALS-TDPMatthew Nolan, Paola Barbagallo, Martin R Turner, et al.
Journal of Neurology|May 25, 2022
Creatine kinase and prognosis in amyotrophic lateral sclerosis: a literature review and multi-centre cohort analysisJiali Gao, Thanuja Dharmadasa, Andrea Malaspina, et al.
Pageof 26

Showing results (101-110 of 255) with videos related to

Sort By:
Pageof 26
Cell Death & Disease|January 31, 2026
Mutant TDP-43 drives impairments in axonal transport and glycolysis in a mouse stem-cell-derived motor neuron model of amyotrophic lateral sclerosis (ALS)Emily Carroll, Jakub Scaber, Iris-Stefania Pasniceanu, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 17, 2020
Motor Neuron Disease Register for England, Wales and Northern Ireland-an analysis of incidence in EnglandSarah Opie-Martin, Lynn Ossher, Andrea Bredin, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|December 17, 2009
Pattern of spread and prognosis in lower limb-onset ALSMartin R Turner, Alice Brockington, Jakub Scaber, et al.
FEBS Letters|June 5, 2007
Crystal structure of human wildtype and S581L-mutant glycyl-tRNA synthetase, an enzyme underlying distal spinal muscular atrophyMuhammed Z Cader, Jingshan Ren, Paul A James, et al.
Annals of Clinical and Translational Neurology|July 16, 2020
CSF chitinases before and after symptom onset in amyotrophic lateral sclerosisElizabeth Gray, Alexander G Thompson, Joanne Wuu, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 30, 2015
The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosisElizabeth Gray, James R Larkin, Tim D W Claridge, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 2, 2022
A survey of current practice in genetic testing in amyotrophic lateral sclerosis in the UK and Republic of Ireland: implications for future planningHugo M De Oliveira, Arunachalam Soma, Mark R Baker, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 1, 2020
Development of LNA Gapmer Oligonucleotide-Based Therapy for ALS/FTD Caused by the C9orf72 Repeat ExpansionChaitra Sathyaprakash, Raquel Manzano, Miguel A Varela, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 17, 2021
Isolated homozygous R217X <i>OPTN</i> mutation causes knock-out of functional C-terminal optineurin domains and associated oligodendrogliopathy-dominant ALS-TDPMatthew Nolan, Paola Barbagallo, Martin R Turner, et al.
Journal of Neurology|May 25, 2022
Creatine kinase and prognosis in amyotrophic lateral sclerosis: a literature review and multi-centre cohort analysisJiali Gao, Thanuja Dharmadasa, Andrea Malaspina, et al.
Pageof 26